Table 3.
Outcomes by Receipt of 1, 2, and ≥2 of the Following Antibiotics: Piperacillin/Tazobactam, Meropenem, Cefepime, Ciprofloxacin, and Levofloxacin
| None | 1 | ≥2 | |
|---|---|---|---|
| No. of patients | 7028 | 23 827 | 15 867 |
| LOS, median (IQR), d | 4 (2–8) | 4 (2–7) | 5 (3–9) |
| Hospital costs, median (IQR), $ | 11 440 (7723–21 159) | 11 781 (8211–19 079) | 13 664 (9295–22 052) |
| 30-d hospital re-admission, % | 10.9 | 9.8 | 9.7 |
| Hospital discharge location, % | |||
| Home | 89.4 | 90.1 | 86.8 |
| Hospital | 8.9 | 8.5 | 11.3 |
| Death | 1.0 | 0.8 | 1.1 |
| Hospice | 0.7 | 0.5 | 0.8 |
Abbreviations: IQR, interquartile range; LOS, length of stay.